Evidence map›Paper›PMID 35047055›Full record

ArticleComputational and mathematical methods in medicine2022

Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients.

Xiaofeng Li, Qiu Wang, Zhicheng Wu, Jiantong Zheng, Ling Ji

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. SDC1 is a critical transmembrane proteoglycan in breast cancer.World journal of surgical oncology · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xiaofeng LiDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Qiu WangDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Zhicheng WuDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
Jiantong ZhengShenzhen Dymind Biotechnology Company Limited, China.
Ling JiDepartment of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.ORCID https://orcid.org/0000-0003-4088-2514
Peking University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne of the most usual gynecological state of tumor is ovarian cancer and is a major reason of gynecological tumor-related global mortality rate. There have been multiple risk elements related to ovarian cancer like the background of past cases associated with breast cancer or ovarian cancer, or excessive body weight issues, case history of smoking, and untimely menstruation or menopause. Because of unclear expressions, more than 70% of the ovarian cancer patient cases are determined during the early stage.

resultsFrom the dataset, a total of 199 differentially expressed genes (DEGs) were identified. Through the KEGG pathway study, it was noted that the DEGs are mainly linked with the AGE-RAGE signaling pathway, central carbon metabolism, and human papillomavirus infection. The survival analysis showed 4 highly expressed hub genes COL4A1, SDC1, CDKN2A, and TOP2A which correlated with overall survival in ovarian cancer patients. Moreover, the expression of the 4 hub genes was validated by the GEPIA database and the Human Protein Atlas.

conclusionThe results have shown that all 4 hub genes were found to be upregulated in ovarian cancer tissues which predict poor prognosis in patients with ovarian cancer.

Indexed as

Gene Regulatory NetworksBiomarkers, TumorCollagen Type IVComputational BiologyCyclin-Dependent Kinase Inhibitor p16Databases, GeneticDNA Topoisomerases, Type IIFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateOvarian NeoplasmsPoly-ADP-Ribose Binding ProteinsPrognosisProtein Interaction MapsSyndecan-1Biomarkers, TumorCDKN2A protein, humanCOL4A1 protein, humanCollagen Type IVCyclin-Dependent Kinase Inhibitor p16DNA Topoisomerases, Type IIPoly-ADP-Ribose Binding ProteinsSDC1 protein, humanSyndecan-1TOP2A protein, human

Identifiers

PMID35047055
PMCPMC8763496
OpenAlexW4205720565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.